A collaborative study involving researchers from Karolinska Institutet has charted the prevalence of severe physical symptom burden amongst Scandinavians for up to two years after a SARS-CoV-2 infection.
Clinical Challenges: Rising Steatotic Liver Disease Prevalence
As rates of obesity and diabetes increase in the U.S. and worldwide, so too does the prevalence of nonalcoholic fatty liver disease (NAFLD). NAFLD, recently